Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology

Hodgkin's Disease

Arizona

Peoria : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

California

Duarte : City of Hope

A Pivotal Study of SGN-35 in Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)

Duarte : City of Hope

Long-Term Follow Up of Recipients of Gene Transfer Research at City of Hope

Los Angeles : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Colorado

Denver : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Florida

Hialeah : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Illinois

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Hines : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Various Cities : Research Center New!

Hodgkin?s Lymphoma Study CLBH589E2214

Indiana

Beech Grove : St. Francis Hospital and Health Centers

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Missouri

Saint Louis : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New Jersey

Newark : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New York

East Syracuse : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Rochester : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Ohio

Various Cities : Research Center New!

Hodgkin?s Lymphoma Study CLBH589E2214

Pennsylvania

Various Cities : Research Center New!

Hodgkin?s Lymphoma Study CLBH589E2214

Rhode Island

Providence : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Texas

Houston : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Various Cities : Research Center New!

Hodgkin?s Lymphoma Study CLBH589E2214

Washington

Seattle : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Various Cities : Research Center New!

Hodgkin?s Lymphoma Study CLBH589E2214

West Virginia

Various Cities : Research Center New!

Hodgkin?s Lymphoma Study CLBH589E2214

Australia

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals